Acepromazine (PromAce)

Acepromazine, commonly known by the brand name PromAce, is a phenothiazine tranquilizer that has been used in veterinary medicine for decades to provide sedation and reduce anxiety in various animal species, including rabbits. This medication belongs to a class of drugs that act on the central nervous system to produce calming effects without causing complete unconsciousness. In rabbit medicine, acepromazine serves as a valuable tool for pre-anesthetic protocols, helping to reduce stress and anxiety before surgical procedures while also decreasing the amount of general anesthesia required for safe sedation. While acepromazine has historically been widely used in rabbit practice, modern rabbit-savvy veterinarians often prefer newer sedative options due to certain limitations specific to rabbit physiology.

The mechanism of action of acepromazine involves blocking dopamine receptors in the central nervous system, which produces its characteristic sedative and anti-anxiety effects. This dopamine antagonism affects various brain regions responsible for arousal, alertness, and emotional responses, leading to a calm and relaxed state in the patient. In rabbits, the medication also produces some degree of muscle relaxation, which can be beneficial during handling and minor procedures. However, it is important to understand that acepromazine provides sedation without significant pain relief, meaning it should be combined with appropriate analgesics when procedures involve any potential for discomfort.

Acepromazine is available in both injectable and oral tablet formulations, though the injectable form is most commonly used in rabbit medicine due to more reliable absorption and faster onset of action. The medication is typically administered intramuscularly or subcutaneously by veterinary staff as part of a pre-anesthetic protocol, with effects generally becoming apparent within fifteen to thirty minutes following injection. Oral administration is possible but results in more variable absorption and longer onset times, making it less practical for most veterinary applications. The duration of sedation typically lasts several hours, which necessitates careful monitoring during the recovery period.

While acepromazine has an established safety record in rabbit medicine when used appropriately, it is essential that this medication only be administered under the direct supervision of a rabbit-savvy veterinarian who understands the unique physiological characteristics of lagomorphs. Rabbits are particularly sensitive to certain medications and respond differently than cats and dogs to many drugs, making proper dosing calculations critical for safety. The medication can cause significant drops in blood pressure and body temperature, which requires careful monitoring and supportive care during and after administration. Pet owners should never attempt to administer acepromazine at home without explicit veterinary guidance, as improper use can lead to serious complications including prolonged sedation, hypothermia, and cardiovascular depression.

The primary indication for acepromazine in rabbit medicine is as a pre-anesthetic medication administered before surgical procedures to reduce anxiety, provide mild sedation, and decrease the total amount of general anesthesia required for safe sedation. When rabbits are stressed or anxious before surgery, they require higher doses of anesthetic agents to achieve adequate sedation levels, which increases the risk of anesthetic complications. By calming the patient before induction of anesthesia, acepromazine helps create safer anesthetic conditions and smoother recoveries. This pre-anesthetic use remains one of the most common applications of acepromazine in rabbit veterinary practice, particularly when combined with other medications as part of a balanced anesthetic protocol.

Beyond pre-surgical sedation, acepromazine may be used to facilitate stressful but necessary veterinary procedures such as radiographs, wound care, or detailed physical examinations in particularly anxious or aggressive rabbits. Some rabbits become extremely stressed during veterinary visits, displaying behaviors ranging from freezing in fear to active aggression, and these responses can make thorough examination difficult or impossible without some form of chemical restraint. Acepromazine provides sufficient calming effect to allow safe handling and examination while minimizing stress-related complications such as sudden death from fear or injury from struggling. However, veterinarians must weigh the benefits of sedation against the risks, particularly in compromised patients.

Acepromazine has historically been used to manage transportation stress in rabbits, particularly during long-distance travel or when moving particularly anxious individuals. The calming effects of the medication can help reduce the significant physiological stress that some rabbits experience during transport, which can otherwise lead to gastrointestinal stasis, self-injury, or even sudden death in extreme cases. However, this use requires careful consideration of ambient temperature conditions, as acepromazine impairs thermoregulation and can predispose rabbits to hypothermia during transport in cool conditions or hyperthermia in warm environments. Most rabbit-savvy veterinarians now recommend alternative approaches to managing transportation anxiety when possible.

In some cases, acepromazine may be prescribed for management of aggressive or extremely fearful behavior in rabbits, though this application requires careful evaluation of underlying causes and consideration of alternative approaches. Behavioral issues in rabbits often stem from pain, fear, territorial responses, or inadequate socialization, and these underlying causes should be addressed rather than simply masking symptoms with sedation. When behavioral modification alone proves insufficient and the behavior poses risks to the rabbit or caregivers, acepromazine may provide temporary management while more comprehensive behavioral interventions are implemented. Long-term use for behavioral management is generally not recommended due to potential adverse effects and the availability of better alternatives.

Veterinarians select acepromazine over alternative sedatives based on several factors including the patient's health status, the specific procedure being performed, available monitoring capabilities, and personal experience with various protocols. Acepromazine's long history of use means extensive clinical experience exists regarding its effects in rabbits, which some practitioners find reassuring compared to newer medications with less established track records. The medication's relatively long duration of action can be advantageous for procedures requiring extended sedation periods, though this same characteristic may be a disadvantage when rapid recovery is desired. Cost considerations may also influence drug selection, as acepromazine is generally less expensive than some newer sedative alternatives.

Dosing of acepromazine in rabbits must be determined by a rabbit-savvy veterinarian based on careful assessment of the individual patient, including accurate body weight, overall health status, age, and the specific indication for sedation. Unlike cats and dogs, rabbits often require different dosing approaches, and the dosages used in other species cannot be directly extrapolated to lagomorphs. Accurate weight measurement is particularly critical in rabbits because small errors in weight estimation can result in significant dosing variations in these relatively small animals. Your veterinarian will calculate the appropriate dose using milligrams per kilogram body weight, ensuring the medication provides adequate effect while minimizing risks of adverse reactions.

The typical dosing approach for acepromazine in rabbits involves lower doses than those used in many other species, as rabbits can be quite sensitive to the cardiovascular and thermoregulatory effects of phenothiazine tranquilizers. When used as a pre-anesthetic, acepromazine is often combined with other medications such as opioid analgesics to provide balanced sedation with better pain control than acepromazine alone can provide. This combination approach allows for reduced doses of each individual drug while achieving superior overall sedation quality. Your veterinarian will determine whether acepromazine alone or a combination protocol is most appropriate for your rabbit's specific situation.

Treatment duration with acepromazine is typically limited to single or occasional doses for specific procedures rather than ongoing daily administration. The sedative effects generally persist for several hours following a single dose, with most rabbits returning to relatively normal activity levels within four to eight hours, though some residual effects may be noticeable for up to twenty-four hours. Unlike medications used for chronic conditions, acepromazine is not intended for regular daily use due to potential for cumulative effects and the development of tolerance over time. Repeat dosing within a short time frame should only occur under direct veterinary supervision with appropriate monitoring.

Administration of acepromazine in rabbits is almost always performed by veterinary staff rather than pet owners due to the need for injectable formulation and careful monitoring during the sedation period. The medication is typically given intramuscularly into the large muscles of the hindquarters or subcutaneously between the shoulder blades, with intramuscular injection generally producing faster and more predictable onset of effects. Rabbits should be kept in a quiet, warm environment following injection, as external stimulation can partially overcome the sedative effects and cold environments can exacerbate hypothermia risk. Food and water do not need to be withheld before acepromazine administration as they do in species at risk of vomiting, since rabbits cannot vomit.

In the unusual circumstance that a dose is missed in a planned sedation protocol, the veterinary team will assess whether to proceed with a delayed dose or reschedule the procedure entirely depending on timing and circumstances. Because acepromazine is typically used for discrete events rather than ongoing treatment, missed doses are managed differently than with chronic medications. If sedation was intended for a time-sensitive procedure, the veterinarian may adjust the protocol or select alternative medications based on the delay. Pet owners should never administer acepromazine at home without explicit instructions, and any concerns about sedation timing should be communicated immediately to the veterinary team.

Completion of treatment with acepromazine involves careful monitoring during the recovery period until the rabbit returns to normal activity and eating behavior. Unlike antibiotics where completing a full course is essential, acepromazine is used on an as-needed basis with the endpoint being successful completion of the indicated procedure and safe recovery from sedation. Owners should observe their rabbit closely following veterinary procedures involving acepromazine, watching for delayed return to normal eating within twelve to twenty-four hours, which could indicate complications requiring veterinary attention. Normal cecotrope production and consumption typically resumes as sedation wears off, and any prolonged changes in gastrointestinal function should prompt immediate veterinary consultation.

Acepromazine has a generally acceptable safety profile in rabbits when administered at appropriate doses under veterinary supervision, though several important side effects must be considered and monitored. Most rabbits tolerate the medication without serious complications when proper protocols are followed, but the potential for adverse effects necessitates careful patient selection and vigilant monitoring throughout the sedation and recovery periods. Understanding the expected and potential unexpected effects of acepromazine helps veterinary teams and pet owners recognize problems early and respond appropriately. The gastrointestinal system in rabbits deserves particular attention, as any medication causing reduced gut motility can trigger the potentially life-threatening condition of gastrointestinal stasis.

The most commonly observed effects of acepromazine in rabbits include expected sedation with reduced activity and responsiveness, mild to moderate drops in blood pressure, and decreased body temperature due to impaired thermoregulation. These effects are generally dose-dependent and more pronounced at higher doses, which is why veterinarians carefully calculate the minimum effective dose for each patient. Some rabbits may appear more deeply sedated than expected even at standard doses, reflecting individual variation in drug sensitivity. Mild changes in respiratory rate are also common, with most sedated rabbits showing somewhat slower and shallower breathing than normal, though this should not progress to obvious respiratory distress.

Moderate side effects that warrant increased monitoring and potential intervention include significant hypotension causing pale mucous membranes or delayed capillary refill time, hypothermia with body temperature dropping below normal range despite warming measures, and prolonged sedation lasting longer than typical durations. Some rabbits may experience temporary changes in gastrointestinal motility, manifesting as reduced fecal pellet production or decreased appetite during and immediately following sedation. These effects typically resolve as the medication wears off, but veterinary teams should be alert for signs suggesting more persistent gastrointestinal slowdown. Occasional paradoxical excitement may occur, particularly if the rabbit is stimulated during the initial absorption phase before full sedation develops.

Serious side effects requiring immediate veterinary attention include severe respiratory depression with labored breathing or cyanosis, profound hypotension causing collapse or shock, extreme hypothermia unresponsive to warming efforts, and complete gastrointestinal stasis persisting beyond the expected duration of drug effect. Signs of GI stasis in rabbits include complete cessation of fecal pellet production, bloated or painful abdomen, teeth grinding indicating pain, and refusal to eat or drink. These signs constitute a medical emergency in any rabbit and require immediate intervention. Severe cardiovascular depression, while uncommon at appropriate doses, can occur in sensitive individuals or those with underlying heart conditions, and may manifest as weakness, collapse, or abnormal heart rhythms.

Rare but documented side effects of acepromazine in rabbits include seizures in susceptible individuals, severe allergic reactions manifesting as facial swelling or difficulty breathing, and profound prolonged sedation lasting twenty-four hours or more. Some rabbits may experience temporary third eyelid protrusion giving an unusual appearance to the eyes, which typically resolves without treatment as the medication wears off. Any reduction in appetite lasting more than twelve hours following expected recovery from sedation warrants veterinary contact, as this may indicate developing gastrointestinal problems requiring intervention. Pet owners receiving their rabbit back after sedation procedures should receive clear written instructions about normal versus concerning signs during the recovery period.

Acepromazine should not be administered to rabbits with known hypersensitivity or previous adverse reactions to phenothiazine tranquilizers, as cross-reactivity within this drug class makes allergic reactions likely upon repeat exposure. Prior severe reactions to acepromazine such as collapse, seizures, or anaphylaxis absolutely preclude future use of this medication and require documentation in the patient's permanent medical record. Even mild reactions during previous acepromazine administration should prompt veterinarians to consider alternative sedative protocols for future procedures. Pet owners should always inform their veterinarian of any previous medication reactions their rabbit has experienced, even if the reaction occurred at a different veterinary practice.

Rabbits with compromised cardiovascular function represent a significant contraindication for acepromazine use due to the medication's hypotensive effects. Animals with pre-existing heart disease, shock, severe dehydration, or significant blood loss are at greatly increased risk of cardiovascular collapse when given medications that further reduce blood pressure and cardiac function. Similarly, rabbits with liver disease may have impaired ability to metabolize acepromazine, leading to prolonged and potentially dangerous drug effects. Kidney disease can also affect drug handling, though the liver plays the primary role in acepromazine metabolism. Any rabbit with suspected organ dysfunction should receive thorough evaluation before acepromazine administration, with alternative protocols considered for significantly compromised patients.

Pregnancy represents a relative contraindication for acepromazine use in rabbits, as the medication crosses the placenta and may affect developing fetuses. While the exact effects of acepromazine on rabbit pregnancy and fetal development are not fully characterized, caution is warranted when sedation is needed in pregnant does. Nursing does should similarly receive acepromazine only when clearly necessary, as the medication may pass into milk and affect nursing kits. If sedation is required in pregnant or lactating rabbits, veterinarians should carefully weigh risks and benefits, use the minimum effective dose, and consider alternative medications with better-established safety profiles in reproduction. Young kits may also be more sensitive to acepromazine's effects, warranting extra caution in pediatric patients.

Other medical conditions that may contraindicate or require extreme caution with acepromazine include seizure disorders, as phenothiazines can lower seizure threshold in susceptible individuals, and pre-existing gastrointestinal stasis, since any additional reduction in gut motility could prove dangerous. Rabbits with head trauma or increased intracranial pressure should not receive acepromazine due to potential effects on cerebral blood flow. Severely debilitated, geriatric, or cachexic rabbits may have altered drug distribution and metabolism, increasing risk of adverse effects. Temperature extremes in the environment contraindicate acepromazine use because impaired thermoregulation combined with cold or hot conditions can rapidly lead to hypothermia or hyperthermia. Your veterinarian will review your rabbit's complete medical history before determining whether acepromazine is safe and appropriate.

Full disclosure of all medications, supplements, and treatments your rabbit receives is essential before acepromazine administration, as numerous potential drug interactions can affect safety and efficacy. This includes prescription medications, over-the-counter products, herbal supplements, and any recent treatments administered by other veterinary practices. Acepromazine interacts with many drug classes through various mechanisms including additive central nervous system depression, enhanced hypotensive effects, and altered drug metabolism. Your veterinarian needs complete information to make safe sedation decisions and adjust protocols appropriately when interactions are anticipated.

Significant interactions occur between acepromazine and other central nervous system depressant medications, with additive sedation and respiratory depression possible when combined with opioids, benzodiazepines, barbiturates, or other sedative agents. While combinations of acepromazine with opioids are intentionally used in balanced anesthetic protocols, the doses must be carefully calculated to account for synergistic effects. Concurrent use with other phenothiazine medications would produce additive effects and should be avoided. Antihypertensive medications combined with acepromazine can cause dangerous drops in blood pressure, and diuretics may exacerbate hypotension through reduced blood volume. Any medications known to prolong cardiac QT interval may have enhanced effects when combined with acepromazine, increasing arrhythmia risk.

Dietary supplements and herbal products commonly used by rabbit owners may interact with acepromazine in unexpected ways. Papaya enzyme supplements given for hairball prevention do not have documented interactions with acepromazine and can generally continue during sedation protocols. However, herbal calming supplements or those containing valerian, chamomile, or other sedative herbs may have additive effects and should be disclosed to your veterinarian. Probiotics are generally safe and often recommended to support gastrointestinal function during and after sedation, as the stress of procedures and effects of medications can disrupt the normal gut microbiome. The timing of acepromazine administration relative to food does not significantly affect its absorption or effectiveness when given by injection.

Monitoring for drug interactions when acepromazine is combined with other medications involves careful attention to depth of sedation, cardiovascular parameters, body temperature, and recovery time. Signs of excessive interaction effects include sedation deeper or longer than anticipated, significant hypotension, hypothermia unresponsive to warming, or delayed return to normal eating and activity following procedures. Your veterinarian may adjust monitoring protocols or recovery care when acepromazine is used in rabbits receiving concurrent medications. Any unexpected responses during sedation should be promptly communicated to the veterinary team for appropriate intervention. Contact your veterinarian immediately if your rabbit shows concerning signs during home recovery after receiving acepromazine with other medications.

General precautions for acepromazine use in rabbits begin with confirmation that administration is truly necessary and that a rabbit-savvy veterinarian has determined the medication is appropriate for the individual patient and situation. Acepromazine should only be administered by trained veterinary staff with appropriate monitoring equipment and the ability to provide supportive care if complications arise. Accurate body weight measurement immediately before dosing helps ensure appropriate drug amounts, as rabbits can experience significant weight fluctuations that affect dosing calculations. Veterinary teams should have emergency drugs and warming equipment readily available whenever acepromazine is administered to rabbits.

Breed-specific considerations for acepromazine include potential increased sensitivity in dwarf breeds due to their small body size and reduced margin for dosing errors. Netherland Dwarfs, Holland Lops, and other small breeds require particularly careful dose calculations, with many veterinarians preferring liquid formulations that allow more precise measurement than tablet fragments. Giant breeds including Flemish Giants may require relatively higher doses on a per-kilogram basis due to differences in drug distribution, though this should be determined by the attending veterinarian rather than assumed. Lop-eared breeds do not have specific acepromazine sensitivities, though their propensity for ear problems may be relevant to the overall sedation protocol if ear procedures are planned.

Environmental precautions during and after acepromazine administration are critical for rabbit safety. The area where the rabbit recovers from sedation should be maintained at comfortable room temperature with supplemental warming provided as needed, since hypothermia is a significant risk with phenothiazine tranquilizers. Bedding should be non-slip to prevent injury as coordination returns, and the enclosure should prevent falls or other trauma during the disoriented recovery period. Household temperature extremes, drafts, and direct sunlight should all be avoided during recovery. Multi-pet households should ensure the sedated rabbit is protected from disturbance by other animals during the vulnerable recovery period.

Monitoring during acepromazine sedation in rabbits should include regular assessment of heart rate, respiratory rate and character, body temperature, mucous membrane color, and capillary refill time. Signs that the medication is providing appropriate effect include quiet, relaxed posture with reduced but present response to stimulation and stable vital parameters. Signs suggesting problems include progressively deepening sedation, pale or blue-tinged mucous membranes, temperature below acceptable range despite warming efforts, or complete loss of response to stimulation. Following return home, owners should monitor appetite, fecal output, activity level, and general demeanor, with any persistent abnormalities beyond twelve to twenty-four hours warranting veterinary contact.

Special populations requiring modified approaches to acepromazine include geriatric rabbits who may have reduced organ function affecting drug metabolism and clearance, potentially requiring lower doses or extended monitoring periods. Young rabbits similarly may have immature metabolic pathways affecting drug handling. Rabbits with chronic conditions such as E. cuniculi infection, dental disease, or previous gastrointestinal problems should be carefully evaluated before acepromazine administration, as stress from underlying conditions may compound sedation risks. Pregnant and nursing does require the additional considerations discussed in the contraindications section, with alternative sedative protocols often preferred when sedation cannot be avoided in these populations.

Acepromazine injectable solution should be stored according to manufacturer recommendations, typically at controlled room temperature between 59 and 86 degrees Fahrenheit, protected from light and excessive heat. The medication should be kept in its original container with the lid tightly closed to prevent contamination and degradation. Storage locations should be away from direct sunlight, heating vents, and areas of temperature fluctuation such as near stoves or in vehicles. The medication should be kept out of reach of children and animals, as accidental ingestion could cause serious sedation effects. Acepromazine tablets, when dispensed, should similarly be stored at room temperature in a childproof container away from light and moisture.

Injectable acepromazine comes in multi-dose vials that have specific handling requirements to maintain sterility and potency throughout their use period. Veterinary staff should inspect the solution before each use, checking for discoloration, particulates, or other signs of degradation that would preclude safe use. The rubber stopper should be cleaned with alcohol before each needle insertion to prevent contamination. Most injectable acepromazine solutions are clear to slightly yellow, and significant color changes indicate degradation. Expiration dates should be strictly observed, and any remaining medication past its expiration date should be properly disposed of rather than used. Some practices apply an opened date label to track appropriate use periods for multi-dose vials.

Safe handling of acepromazine requires attention to human exposure prevention, as the medication can cause sedation if accidentally absorbed through skin contact or mucous membrane exposure. Veterinary staff should wear gloves when handling the medication, particularly when drawing up doses or if spills occur. Pregnant staff members may be advised to avoid handling phenothiazine medications, and anyone who experiences accidental exposure should wash the affected area immediately and seek medical attention if sedation effects develop. Proper disposal of acepromazine follows controlled substance regulations in most jurisdictions, though the medication itself is not a controlled substance. Drug take-back programs and veterinary waste disposal services provide appropriate disposal options. Pet owners receiving tablets for home administration should return any unused medication to the veterinary clinic for proper disposal rather than disposing through household trash or flushing.

Acepromazine can be used in most rabbit breeds when appropriately indicated, though certain breed characteristics warrant specific consideration when planning sedation protocols. The significant size variation among rabbit breeds, ranging from dwarf breeds weighing under two pounds to giant breeds exceeding fifteen pounds, creates the most important breed-related consideration for acepromazine dosing. This weight variation affects not only the total drug dose but also the formulation selected and precision required for safe administration. Veterinarians experienced with rabbits understand these variations and adjust their protocols accordingly.

Dwarf breeds including Netherland Dwarfs, Holland Lops, Mini Rex, and similar small rabbits require exceptional dosing precision when receiving acepromazine. In an animal weighing less than two kilograms, small errors in dose calculation can result in significant under- or over-dosing with corresponding impacts on efficacy or safety. Many veterinarians prefer diluted injectable solutions or liquid formulations that permit more accurate measurement of small volumes for these tiny patients. Dwarf breeds may also have relatively higher metabolic rates affecting drug distribution and elimination, potentially requiring protocol adjustments. Some individual dwarf rabbits demonstrate heightened sensitivity to sedative medications, warranting conservative initial dosing with the option to supplement if needed.

Giant breeds such as Flemish Giants, Continental Giants, and Checkered Giants present different considerations for acepromazine administration. These large rabbits require proportionally higher absolute drug doses, which may approach or exceed volumes conveniently delivered in a single injection site. Drug distribution in larger body masses may differ from smaller rabbits, sometimes requiring dose adjustments based on clinical response rather than simple weight-based calculations. Giant breeds are prone to musculoskeletal issues including arthritis and spondylosis, which may be relevant when positioning sedated patients for procedures. The size of these rabbits also affects handling and monitoring logistics during sedation and recovery periods.

Age-related considerations overlay breed factors when evaluating acepromazine use in rabbits. Pediatric rabbits regardless of breed have developing organ systems that may affect drug metabolism differently than in adults, generally warranting conservative dosing and careful monitoring. Senior rabbits commonly have age-related decline in liver and kidney function affecting drug clearance, potentially resulting in prolonged sedation and increased adverse effect risk. Geriatric rabbits are also more likely to have concurrent health conditions that may influence sedation protocol selection and monitoring requirements. Your rabbit-savvy veterinarian will evaluate your rabbit's breed characteristics, age, health status, and the specific indication for sedation when determining the most appropriate and safest approach to acepromazine administration.

Alternative sedative medications in the same phenothiazine class as acepromazine are rarely used in rabbit medicine, as acepromazine represents the most commonly available and studied phenothiazine option for veterinary patients. When phenothiazine tranquilizers are contraindicated or have proven ineffective in a particular rabbit, veterinarians typically select medications from entirely different drug classes rather than attempting other phenothiazines. This approach provides different mechanisms of action and side effect profiles that may be better suited to individual patients. Your veterinarian can discuss whether acepromazine or an alternative sedative class is most appropriate for your rabbit's needs.

Alpha-2 adrenergic agonists including medetomidine and dexmedetomidine represent commonly used alternatives to acepromazine for rabbit sedation and pre-anesthesia. These medications produce reliable sedation with the significant advantage of reversibility using the antagonist atipamezole, allowing rapid recovery when the procedure is complete. Alpha-2 agonists do carry their own risk profile including cardiovascular effects and are not appropriate for all patients, but many rabbit-savvy veterinarians prefer them over acepromazine for routine sedation needs. Benzodiazepines such as midazolam and diazepam provide anxiolysis and muscle relaxation with minimal cardiovascular effects, making them useful components of balanced sedation protocols, though they rarely provide adequate sedation as sole agents in rabbits.

Complementary therapies supporting rabbits receiving acepromazine include active warming during and after sedation to combat hypothermia, intravenous or subcutaneous fluid therapy to support cardiovascular function, and supplemental oxygen when respiratory depression is noted. Probiotics may be administered to support gastrointestinal function during the peri-sedation period when normal eating patterns are disrupted. Critical Care or similar recovery foods can be offered as appetite returns to help maintain gut motility. Simethicone may be useful if gas accumulation is noted during recovery. Never substitute alternative sedative medications for acepromazine without veterinary guidance, as all sedative agents carry specific risks requiring professional evaluation and monitoring. Your rabbit-savvy veterinarian can discuss the full range of sedation options and determine which approach offers the best balance of effectiveness and safety for your rabbit's specific situation and health status.